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Background: Glioblastoma is the most aggressive form of brain tumors showing resistance to treatment with
various chemotherapeutic agents. The most effective way to eradicate glioblastoma requires the concurrent
inhibition of multiple signaling pathways and target molecules involved in the progression of glioblastoma.
Recently, we obtained a series of 1,2,3,4-tetrahydroisoquinoline alkaloids with potent anti-cancer activities, including
ecteinascidin-770 (ET-770; the compound 1a) and renieramycin M (RM; the compound 2a) from Thai marine
invertebrates, together with a 2’-N-4”-pyridinecarbonyl derivative of ET-770 (the compound 3). We attempted to
characterize the molecular pathways responsible for cytotoxic effects of these compounds on a human
glioblastoma cell line U373MG.
Methods: We studied the genome-wide gene expression profile on microarrays and molecular networks by using
pathway analysis tools of bioinformatics.
Results: All of these compounds induced apoptosis of U373MG cells at nanomolar concentrations. The compound
3 reduced the expression of 417 genes and elevated the levels of 84 genes, while ET-770 downregulated 426 genes
and upregulated 45 genes. RM decreased the expression of 274 genes and increased the expression of 9 genes.
The set of 196 downregulated genes and 6 upregulated genes showed an overlap among all the compounds,
suggesting an existence of the common pathways involved in induction of apoptosis. We identified the ErbB
(EGFR) signaling pathway as one of the common pathways enriched in the set of downregulated genes, composed
of PTK2, AKT3, and GSK3B serving as key molecules that regulate cell movement and the nervous system
development. Furthermore, a GSK3B-specific inhibitor induced apoptosis of U373MG cells, supporting an anti-
apoptotic role of GSK3B.
Conclusion: Molecular network analysis is a useful approach not only to characterize the glioma-relevant pathways
but also to identify the network-based effective drug targets.Background
Glioblastoma, World Health Organization (WHO) grade
IV, is the most common and aggressive form of primary
malignant brain tumors affecting the adult human brain.
Glioblastoma is categorized into two distinct subtypes that
develop through different genetic and molecular path-
ways, designated as primary glioblastoma and secondary* Correspondence: satoj@my-pharm.ac.jp
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reproduction in any medium, provided the orglioblastoma [1]. Primary glioblastoma that develops with-
out precursor lesions shows an amplification of the
epidermal growth factor receptor (EGFR) gene more fre-
quently than secondary glioblastoma that generates via
the stepwise progression from the pre-existing low-grade
glioma. EGFR amplification in primary glioblastoma is
often associated with the expression of EGFRvIII, a lig-
and-independent constitutively active mutant of EGFR,
capable of persistently activating the phosphatidylinositol
3-kinase (PI3K)/v-akt murine thymoma viral oncogene
homolog (AKT) signaling pathway that promotes theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phosphatase and tensin homolog (PTEN), a negative
regulator of AKT signaling pathway, are more frequent
found in primary glioblastoma. In contrast, secondary
glioblastoma more often shows tumor protein p53
(TP53) mutations, and fairly consistently exhibits the
genetic mutation of isocitrate dehydrogenase 1 (IDH1),
a negative regulator of hypoxia-inducible factor 1-alpha
(HIFA), whereas IDH1 mutations are barely detectable
in primary glioblastoma [1].
Despite the multidisciplinary therapy that combines
maximal surgical resection, radiation and chemotherapy,
the median survival period does not usually exceed
2 years in the patients with glioblastoma owing to the
high incidence of recurrence, invasion, and progression
of the tumors [3]. The current drugs that specifically tar-
get the tyrosine kinase activity of EGFR or selectively in-
hibit the mammalian target of rapamycin (mTOR), a
PI3K/AKT downstream signal transducer showed little
efficacy in treatment of primary glioblastoma [3]. These
observations suggest that the best way to eradicate glio-
blastoma requires the concurrent inhibition of multiple
signaling pathways and target molecules that play a piv-
otal role in the survival and progression of glioma cells.
After the completion of the Human Genome Project,
the global analysis of genome, transcriptome, proteome,
and metabolome, collectively termed omics, promotes us
to characterize the genome-wide molecular basis of the
diseases, and helps us to identify disease-specific mo-
lecular signatures and biomarkers for diagnosis, classifi-
cation, and prediction of prognosis. Because omics
studies usually produce high-throughput experimental
data at one time, it is often difficult to find out the
meaningful biological implications from such a huge
dataset. Recent advances in bioinformatics and systems
biology have made major breakthroughs by illustrating
the cell-wide map of complex molecular interactions
with the aid of the literature-based knowledgebase of
molecular pathways [4]. The logically arranged molecu-
lar networks construct the whole system characterized
by robustness, which maintains the proper function of
the system in the face of genetic and environmental per-
turbations. In the scale-free molecular networks, tar-
geted disruption of limited numbers of critical
components designated hubs, on which the biologically
important molecular connections concentrate, could dis-
turb the whole cellular function by destabilizing the net-
works [5]. Based on these views, the integration of omics
data derived from glioma cells with underlying molecu-
lar networks provides a useful approach not only to
characterize the glioma-relevant pathways but also to
identify the network-based effective drug targets.
Various tetrahydroisoquinoline alkaloids with anti-can-
cer activities were isolated from marine invertebrates.They are classified into two major categories, ecteinasci-
dins and renieramycins and their related compounds.
The most potent bioactive member of ecteinascidins is
ecteinascidin-743 (ET-743; the compound 1b in Figure 1,
Trabectedin, Yondelis, CID 108150) isolated from the
Carribean tunicate Ecteinascidia turbinata. The Euro-
pean Commission has approved ET-743 for the first-line
therapy in the patients with unresectable soft tissue sar-
coma refractory to the conventional chemotherapy [6].
ET-743 has a unique mechanism of anti-cancer activity
in that it binds to the minor groove of the DNA double
helix and alkylates the N2 of guanine to interfere with
cell division, DNA repair, and transcriptional activation,
leading to apoptosis of target cells [7–9].
Previously, we purified and identified a series of bio-
logically active compounds from Thai marine inverte-
brates. Among them, ecteinascidin-770 (ET-770; the
compound 1a in Figure 1, CID 16728498) is a stabilized
derivative of ET-743 that maintained anti-cancer activities,
obtained on a large scale from Thai tunicate Ecteinascidia
thurstoni by pretreatment with potassium cyanide in buf-
fer solution [10]. Recently, we prepared nitrogen-contain-
ing heterocyclic derivatives of ET-770, and we found that
a 2’-N-4”-pyridinecarbonyl derivative of ET-770 (the com-
pound 3 in Figure 1) shows the greater cytotoxicity to
human colon, lung and prostate cancer cells than the
compound 1a [11]. We also isolated renieramycin M (RM;
the compound 2a in Figure 1), a major bis-1,2,3,4-tetrahy-
droisoquinolinequinone alkaloid from the Thai marine
sponge Xestospongia sp., which exhibits a potent cytotox-
icity to human colon and breast cancer cells at the nano-
molar concentrations [12]. Transcriptome analysis of the
compound 2a-treated cancer cells suggested that the
downregulation of protein tyrosine phosphatase receptor
type K (PTPRK) serves as a biomarker for monitoring
anti-tumor effects of RM [13]. Furthermore, RM induces
apoptosis through the p53-dependent pathway and inhi-
bits progression and metastasis of lung cancer cells at low
sublethal concentrations [14].
The present study attempted to characterize and eluci-
date the molecular pathways responsible for cytotoxic
effects of three distinct marine-derived anti-cancer
1,2,3,4-tetrahydroisoquinoline alkaloids 1a, 2a, and 3 on
a human glioblastoma cell line U373MG by investigating




The isolation, purification, chemical synthesis, and
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compound 2a), ecteinascidin-770 (ET-770, the com-
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Figure 1 The structures of novel 1,2,3,4-tetrahydroisoquinoline alkaloids. Ecteinascidin-770 (ET-770, the compound 1a), Ecteinascidin-743
(ET-743, the compound 1b), renieramycin M (the compound 2a), renieramycin E (the compound 2b), and a 2’-N-4”-pyridinecarbonyl derivative of
ET-770 (the compound 3) are shown. The present study focused on cytotoxic effects of the compounds 1a, 2a, and 3.
Tabunoki et al. Cancer Cell International 2012, 12:14 Page 3 of 16
http://www.cancerci.com/content/12/1/14detail [10–15]. The chemical structures of these com-
pounds are shown in Figure 1. For a stock solution, all
of them are dissolved at the concentration of 10 mM in
dimethyl sulfoxide (DMSO), and further diluted with
culture medium at a working concentration prior to use.
An equivalent concentration (v/v) of vehicle (DMSO)
was included to serve as negative controls.a
c
Figure 2 Induction of apoptosis of U373MG cells by exposure to the
72 hours to the chemical compounds individually at the concentration of I
vehicle (DMSO), or (b) ET-770, the compound 1a, (c) ET-770 derivative, the
round-shaped cells with remarkable shrinkage indicate the cells with ongoTreatment of U373MG glioblastoma cells with anti-cancer
chemical compounds
To determine the 50 % inhibitory concentration (IC50),
U373MG human glioblastoma cells, incubated in Dul-
becco’s Modified Eagle’s medium (DMEM; Invitrogen,
Carlsbad, CA, USA) supplemented with 10 % fetal bo-
vine serum (FBS), 100 U/ml penicillin and 100 μg/mlb
d
anti-cancer chemical compounds. U373MG cells were exposed for
C50. The panels (a-d) represent phase contrast photographs of (a) the
compound 3, and (d) renieramycin M (RM), the compound 2a. The
ing apoptosis.
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Figure 3 Detection of apoptosis of U373MG cells by exposure to the anti-cancer chemical compounds. U373MG cells were exposed to
the chemical compounds individually at the concentration of IC50 for 72 hours or 20 μM GSK3B inhibitor VII for 36 hours. They were then
processed for western blot analysis. The panels (A-D) represent the blot of (A) ET-770, the compound 1a, (B) ET-770 derivative, the compound 3,
(C) RM, the compound 2a, and (D) GSK3B inhibitor VII. The panels (a-l) indicate the blot of (a, d, g, j) poly-ADP-ribose-polymerase (PARP)
composed of an 116-kDa uncleaved product and an 85-kDa cleaved product, (b, e, h, k) caspase-3 (CASP3) composed of 19-kDa and 17-kDa
cleaved products, and (c, f, i, l) heat shock protein HSP60, an internal control of protein loading. The lanes (1–16) represent the cells (1, 7)
untreated or treated for (2, 8) 4 hours, (3, 9) 8 hours, (4, 10) 24 hours, (16) 36 hours, (5, 11) 48 hours, and (6, 12, 14) 72 hours with the
compounds or (13) 72 hours with the vehicle (DMSO), and (15) 36 hours with the vehicle (DMSO).
RM(274)






















Downregulated Genes Upregulated Genes
Figure 4 The genes downregulated or upregulated in U373MG cells following exposure to the anti-cancer chemical compounds. The
genome-wide gene expression profile was studied in U373MG cells exposed for 24 hours to the vehicle (DMSO) or to the chemical compounds
1a, 2a, or 3 individually at the concentration of IC50. The fold changes greater than 3 or smaller than 0.3333, calculated by the expression levels
in the compound-treated cells divided by those in the vehicle-treated cells, were considered as substantial upregulation or downregulation. The
number of downregulated or upregulated genes is shown.
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Table 1 Top 10 genes downregulated or upregulated in U373MG cells following exposure to anti-cancer chemical
compounds
ET-770 (the Compound 1a) ET-770 Derivative (the Compound 3) RM (the Compound 2a)
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Table 1 Top 10 genes downregulated or upregulated in U373MG cells following exposure to anti-cancer chemical
compounds (Continued)
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The genome-wide gene expression profile was studied on Human Gene 1.0 ST array in U373MG cells following a 24 hour-exposure to the vehicle (DMSO) or to
the three chemical compounds (Figure 1) individually at the concentration of IC50. The fold changes greater than 3 or smaller than 0.3333, calculated by the
expression levels in the compound-treated cells divided by those in the vehicle-treated cells, were considered as substantial upregulation or downregulation. Top
ten of them are listed with gene symbol, gene name, and fold change.
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http://www.cancerci.com/content/12/1/14streptomycin (feeding medium), were exposed to the
chemical compounds for varying periods at variable
concentrations. Then, we assessed the cell viability by(a)
(c)
Figure 5 qPCR of PTK2, AKT3, GSK3B, and CDC25A mRNAs in U373M
compounds. The panels (a-d) indicate quantitative RT-PCR (qPCR) analysis
standardized against the levels of G3PDH in U373MG cells exposed for 4 h
(M1), or for 24 hours to DMSO (D2) or ET-770, the compound 1a (E2), indmorphological observations and by using the 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) cell growth kit (Millipore, Temecula, CA, USA).(b)
(d)
G cells following exposure to the anti-cancer chemical
of (a) PTK2, (b) AKT3, (c) GSK3B, and (d) CDC25A mRNA expression
ours or 24 hours to DMSO (D1) or ET-770 derivative, the compound 3
ividually at the concentration of IC50.
Table 2 KEGG pathways of the genes downregulated or upregulated in U373MG cells following exposure to anti-cancer chemical compounds
ET-770 (the Compound 1a) ET-770 Derivative (the Compound 3) RM (the Compound 2a)
Downregulated Genes (n = 426) Downregulated Genes (n = 417) Downregulated Genes (n =274)
Rank Pathway P-Value FDR Rank Pathway P-Value FDR Rank Pathway P-Value FDR
1 hsa04012:ErbB
signaling pathway
0.0006 0.71 1 hsa04510:Focal
adhesion
0.0001 0.12 1 hsa04070:Phosphatidy
linositol signaling system
0.0003 0.38
2 hsa04360:Axon guidance 0.0008 0.94 2 hsa04360:Axon
guidance




0.0041 4.69 3 hsa04810:Regulation
of actin cytoskeleton





0.0052 5.82 4 hsa04020:Calcium signaling pathway 0.0083 9.21 4 hsa04510:Focal adhesion 0.0032 3.51
5 hsa05214:Glioma 0.0076 8.42 5 hsa04012:ErbB
signaling pathway






0.0097 10.63 6 hsa04012:ErbB
signaling pathway
0.0046 5.10
7 hsa05214:Glioma 0.0053 5.86




10 hsa04360:Axon guidance 0.0084 9.08
Upregulated Genes (n= 45) Upregulated Genes (n= 84) Upregulated Genes (n= 9)
Rank Pathway P-Value FDR Rank Pathway P-Value FDR Rank Pathway P-Value
1 hsa04110:Cell cycle 0.0053 4.58 1 hsa04110:Cell cycle 0.0077 6.84 none
The genome-wide gene expression profile was studied on Human Gene 1.0 ST array in U373MG cells following a 24 hour-exposure to the vehicle (DMSO) or to the three chemical compounds (Figure 1). By importing
the complete list of Entrez Gene IDs of downregulated or upregulated genes into the Functional Annotation tool of DAVID, the KEGG pathways related to the set of imported genes showing p< 0.01 by a modified













Figure 6 Molecular network of downregulated genes in U373MG cells following exposure to ET-770, the compound 1a. Entrez Gene IDs
of 426 downregulated genes in U373MG cells following a 24 hour-exposure to the compound 1a were imported into the Functional Annotation
tool of DAVID. The KEGG pathways closely related to the set of imported genes were identified. The ErbB (EGFR) signaling pathway (hsa04012),
identified as the first-rank downregulated pathway (Table 2), is shown, where downregulated genes are colored by blue.
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ing medium with inclusion of the chemical com-
pounds at the IC50 concentration or the vehicle, and
then were processed for western blot and microarray
analysis. In some experiments, the cells were exposed
for 36 hours to 20 μM glycogen synthase kinase 3-beta
(GSK3B) inhibitor VII (EMD Chemicals, Gibbstown,
NJ, USA).
qPCR analysis
Total cellular RNA was extracted by using TRIZOL
(Invitrogen). RNA treated with DNase I was processed
for cDNA synthesis using oligo(dT)20 primers and
SuperScript II reverse transcriptase (Invitrogen). For
quantitative RT-PCR (qPCR) analysis, cDNA was ampli-
fied by PCR in LightCycler ST300 (Roche Diagnostics,
Tokyo, Japan) using SYBR Green I and a panel of sense
and antisense primer sets following: 5’ atgaccagcctccag-
caagagtac3’ and 5’ agagggtagcaagacgtgctccta3’ for an
167 bp product of PTK2 protein tyrosine kinase 2(PTK2); 5’cagatgtctccagtggactactgt3’ and 5’gttgtagagg-
catccatctcttcc3’ for an 192 bp product of v-akt murine
thymoma viral oncogene homolog 3 (AKT3); 5’gtaatc-
cacctctggctaccatcc3’ and 5’aggtggagttggaagctgatgcag3’ for
an 156 bp product of GSK3B; 5’gttgcagtcttgcgtgtggatgg3’
and 5’ggtgaccatgggaagcccatttg3’ for an 190 bp product
of cell division cycle 25 homolog A (CDC25A); and
5’ccatgttcgtcatgggtgtgaacca3’ and 5’gccagtagaggcagg-
gatgatgttc3’ for a 251 bp product of the glyceralde-
hyde-3-phosphate dehydrogenase (G3PDH) gene. The
expression levels of target genes were standardized
against the levels of G3PDH, an internal control,
detected in the corresponding cDNA samples. All
the assays were performed in triplicate.
Microarray analysis
For microarray analysis, total cellular RNA was isolated
by using the TRIZOL Plus RNA Purification kit (Invitro-
gen). The quality of total RNA was evaluated on Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,
Figure 7 Molecular network of upregulated genes in U373MG cells following exposure to ET-770 derivative, the compound 3. Entrez
Gene IDs of 84 upregulated genes in U373MG cells following a 24 hour-exposure to the compound 3 were imported into the Functional
Annotation tool of DAVID. The KEGG pathways closely related to the set of imported genes were identified. The cell cycle pathway (hsa04110),
identified as the first-rank upregulated pathway (Table 2), is shown, where upregulated genes are colored by orange.
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cRNA synthesis, fragmentation, and terminal labeling
with the GeneChip Whole Transcript Sense Target La-
beling and Control Reagents (Affymetrix, Santa Clara,
CA, USA). Then, it was processed for hybridization at
45°C for 17 hours with Human Gene 1.0 ST Array
(28,869 genes; Affymetrix). The arrays were washed in
the GeneChip Fluidic Station 450 (Affymetrix), and
scanned by the GeneChip Scanner 3000 7G (Affymetrix).
The raw data were expressed as CEL files and normal-
ized by the robust multiarray average (RMA) method
with the Expression Console software (Affymetrix). Prin-
cipal component analysis (PCA) of RMA-normalized
data was performed on GeneSpring 11.5.1 (Agilent
Technologies). All microarray data are available from
the Gene Expression Omnibus (GEO) repository under
the accession number GSE33619.
We performed three sets of the experiments independ-
ently, composed of the comparisons between thecompound 1a and DMSO, between the compound 2a
and DMSO, and between the compound 3 and DMSO.
Each sample was processed individually for one array.
Fold changes greater than 3 or smaller than 0.3333, cal-
culated by the expression levels in the compound-treated
cells divided by those in the vehicle-treated cells, were
considered as substantial upregulation or downregulation.Molecular network analysis
The annotation of differentially expressed genes was
studied by searching them on the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID)
(david.abcc.ncifcrf.gov) [16]. To identify biologically rele-
vant molecular networks of these genes, three distinct
pathway analysis tools of bioinformatics endowed with
comprehensive knowledgebase were used, including
Kyoto Encyclopedia of Genes and Genomes (KEGG)
(www.kegg.jp), Ingenuity Pathways Analysis (IPA)
Table 3 IPA networks of the genes downregulated or upregulated in U373MG cells following exposure to anti-cancer
chemical compounds
ET-770 (the Compound 1a) ET-770 Derivative (the Compound 3) RM (the Compound 2a)
Downregulated Genes (n= 426) Downregulated Genes (n = 417) Downregulated Genes (n= 274)
Rank Associated Network
Functions
P-Value Rank Associated Network
Functions
P-Value Rank Associated Network
Functions
P-Value




1.00E-45 1 Cardiovascular Disease,
Tissue Development, Post-
Translational Modification





























4 Gene Expression, Infectious
Disease, Cellular
Development
1.00E-34 4 Cellular Movement, Cellular
Growth and Proliferation,
Carbohydrate Metabolism









1.00E-28 5 Gene Expression, Cellular
Development, Cellular
Growth and Proliferation






Upregulated Genes (n = 45) Upregulated Genes (n = 84) Upregulated Genes (n= 9)
Rank Associated Network
Functions
P-Value Rank Associated Network
Functions
P-Value Rank Associated Network
Functions
P-Value
1 Cell Cycle, Gene Expression,
Cell Death
1.00E-41 1 Cellular Growth and
Proliferation, Cell Cycle, Cell-
To-Cell Signaling and
Interaction







1.00E-27 2 Gene Expression, Infectious
Disease, Cell-To-Cell
Signaling and Interaction



















1.00E-03 4 Cellular Movement, DNA
Replication, Recombination,
and Repair, Gene Expression
1.00E-11
5 Cell Death, Post-
Translational Modification,
Amino Acid Metabolism




The genome-wide gene expression profile was studied on Human Gene 1.0 ST array in U373MG cells following a 24 hour-exposure to the vehicle (DMSO) or to
the three chemical compounds (Figure 1). By importing the complete list of Entrez Gene IDs of downregulated or upregulated genes into IPA, the molecular
networks related to the set of imported genes were identified. The networks are listed with the functional category and p-value.
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http://www.cancerci.com/content/12/1/14(Ingenuity Systems; www.ingenuity.com), and KeyMol-
net (Institute of Medicinal Molecular Design; www.immd.
co.jp).
KEGG includes manually curated reference pathways
that cover a wide range of metabolic, genetic, environ-
mental, and cellular processes, and human diseases. Cur-
rently, KEGG contains 158,816 distinct pathwaysgenerated from 417 reference pathways. By importing
the list of Entrez Gene IDs into the Functional Annota-
tion tool of DAVID, it identifies KEGG pathways and
Gene Ontology (GO) categories composed of the genes
enriched in the given set with statistical significance
evaluated by the modified Fisher’s exact test. We have
adjusted the EASE score threshold as 0.01 for the
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http://www.cancerci.com/content/12/1/14Functional Annotation tool of DAVID. The impact fac-
tor (IF) analysis that considers exact fold changes of dif-
ferentially expressed genes for generation of the
corresponding KEGG pathway was performed by using
the Pathway-Express tool (Onto-Tools, Intelligent Sys-
tems and Bioinformatics Laboratory) [17].
IPA is a knowledgebase that contains approximately
2,500,000 biological and chemical interactions and func-
tional annotations with definite scientific evidence,
curated by expert biologists. By uploading the list of
Gene IDs and expression values, the network-generation
algorithm identifies focused genes integrated in a global
molecular network. The network score, based on the
hypergeometric distribution, is calculated by the right-
tailed Fisher’s exact test not followed by multiple testing
corrections. The network score represents the negative
log of the p-value.
KeyMolnet contains knowledge-based contents on
137,300 relationships among human genes and proteins,
small molecules, diseases, pathways and drugs, curated
by expert biologists [4]. They are categorized into the
core contents collected from selected review articles
with the highest reliability or the secondary contents
extracted from abstracts of PubMed and Human Refer-
ence Protein database (HPRD). By importing the list of
Entrez Gene IDs, KeyMolnet automatically provides cor-
responding molecules as a node on networks. The
neighboring network-search algorithm selects one or
more molecules as starting points to generate the net-
work of all kinds of molecular interactions around start-
ing molecules, including direct activation/inactivation,
transcriptional activation/repression, and the complex
formation within the designated number of paths from
starting points. The generated network was compared
side by side with 459 human canonical pathways in-
stalled in the KeyMolnet library. The algorithm counting
the number of overlapping molecular relations between
the extracted network and the canonical pathway makes
it possible to identify the canonical pathway showing the
statistically significant contribution to the extracted net-
work. The network-searching algorithm operating on
KeyMolnet was described previously [4].
Western blot analysis
To prepare total protein extract, the cells were homoge-
nized in RIPA buffer supplemented with a cocktail of
protease inhibitors (Sigma, St. Louis, MO, USA). The
protein extract was centrifuged at 12,000 rpm for 5 min
at room temperature (RT). The protein concentration
was determined by a Bradford assay kit (BioRad
Hercules, CA, USA). The mixture of the supernatant
and a 2X Lammeli loading buffer was boiled and sepa-
rated on a 12% SDS-PAGE gel. After gel electrophoresis,
the protein was transferred onto nitrocellulosemembranes, and immunolabeled at RT overnight with
rabbit anti-poly-ADP-ribose-polymerase (PARP) anti-
body (#11835238001; Roche Diagnostics) or rabbit anti-
cleaved caspase-3 (CASP3, Asp175) antibody (#9661;
Cell Signaling Technology, Danvers, MA, USA). Then,
the membranes were incubated at RT for 60 min with
HRP-conjugated anti-rabbit IgG (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). The specific reaction was visua-
lized by exposing the membranes to a chemilumines-
cent substrate (Thermo Scientific, Rockford, IL, USA).
Then, the antibodies were stripped by incubating the
membranes at 50°C for 30 min in stripping buffer, com-
posed of 62.5 mM Tris–HCl, pH 6.7, 2% SDS and
100 mM 2-mercaptoethanol. The membranes were pro-
cessed for relabeling with goat anti-heat shock protein
HSP60 antibody (sc-1052, N-20; Santa Cruz Biotechnology)
used for an internal control of protein loading, followed
by incubation with HRP-conjugated anti-goat IgG
(Santa Cruz Biotechnology).
Results
Induction of apoptosis of U373MG cells by exposure to
the anti-cancer chemical compounds
First of all, we determined the IC50 concentration of the
compounds 1a, 2a, and 3 for killing U373MG glioblastoma
cells in culture by using the MTT assay. We identified
IC50 as 4.83 nM for the compound 1a, 3.10 nM for the
compound 2a, and 1.70 nM for the compound 3 by a 72
hour-treatment, indicating that very low concentrations of
the chemical compounds are sufficient to induce cell
death of U373MG (Figure 2, panels b-d). The exposure of
U373MG cells for 72 hours to each chemical compound
at the concentration of IC50 induced the cleavage of PARP
and CASP3, both of which reflect molecular markers of
ongoing apoptosis (Figure 3, panels a, b, d, e, g, h, lanes 6,
12, 14).
Gene expression profile of U373MG cells following
exposure to the anti-cancer chemical compounds
Next, by using Human Gene 1.0 ST Array, we studied the
genome-wide gene expression profile of U373MG cells
exposed for 24 hours to the vehicle (DMSO) or to the com-
pounds 1a, 2a, or 3 individually at the concentration of
IC50. We performed three sets of the experiments inde-
pendently, composed of the comparative analysis between
the compound 1a and DMSO, between the compound 2a
and DMSO, and between the compound 3 and DMSO.
Principal component analysis (PCA) showed that the
microarray data derived from the chemical compound-trea-
ted cells and those from DMSO-treated cells constituted
two spatially-separated planes, suggesting that the treat-
ment with the chemical compounds exhibits the much
greater impact on gene expression profile than the levels of
gene expression changes simply attributable to the
Figure 8 Molecular network of downregulated genes in U373MG cells following exposure to renieramycin M, the compound 2a. Entrez
Gene IDs of 274 downregulated genes in U373MG cells following a 24 hour-exposure to the compound 2a were imported into IPA. The
molecular networks closely related to the set of imported genes were identified. The molecular network defined by “cellular movement, cell
morphology, cell-to-cell signaling and interaction” identified as the third-rank downregulated network (Table 3) is shown, where downregulated
genes are colored by green.
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considered the fold changes greater than 3 or smaller than
0.3333, calculated by the expression levels in the com-
pound-treated cells divided by those in the vehicle-treated
cells, as substantial upregulation or downregulation.
We identified a battery of downregulated genes and
upregulated genes following treatment with each chemical
compound (Figure 4). The compound 3 reduced the ex-
pression of 417 genes and elevated the levels of 84 genes,
while the compound 1a downregulated 426 genes and
upregulated 45 genes. The compound 2a decreased the
expression of 274 genes and increased the expression of 9genes. Overall, downregulated genes greatly outnumbered
upregulated genes in each chemical compound. Top 10
genes downregulated or upregulated in U373MG are
listed in Table 1. The complete list of all differentially
expressed genes is available online as Additional files:
Tables S1, S2, S3, S4, S5 and S6.
Importantly, 196 downregulated genes and 6 upregu-
lated genes showed an overlap among three distinct
compounds (all were listed in Additional file 8: Table
S7), suggesting an existence of the common molecular
pathways involved in apoptosis induced by these chem-
ical compounds. It is worthy to note that engulfment
Figure 9 Molecular network of downregulated and upregulated genes in U373MG cells following exposure to the compounds 1a and
3. Entrez Gene IDs of the combined set of 317 downregulated genes and 30 upregulated genes in U373MG cells shared by the compounds 1a
and 3 were imported into KeyMolnet. The neighboring network-search algorithm on core contents illustrated the highly complex molecular
network showing the most significant relationship with transcriptional regulation by Rb/E2F. Red or blue nodes represent upregulated or
downregulated genes, respectively. White nodes exhibit the molecules extracted automatically from the core contents of KeyMolnet to establish
molecular connections. The molecular relation is indicated by solid line with arrow (direct binding or activation), solid line with arrow and stop
(direct inactivation), solid line without arrow (complex formation), dash line with arrow (transcriptional activation), and dash line with arrow and
stop (transcriptional repression). The red circle indicates the E2F family of transcription factors.
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main containing 3 (PSD3) were identified in the list of
downregulated genes, while odd-skipped related 2
(OSR2), heparin-binding EGF-like growth factor
(HBEGF), and zinc finger protein 844 (ZNF844) were
included in upregulated genes shared among three
chemical compounds (Table 1).
Supporting the microarray analysis data, qPCR analysis
validated substantial downregulation of PTK2, AKT3,
and GSK3B and notable upregulation of CDC25A in
U373MG cells following exposure to the compounds 3
and 1a (Figure 5).
Molecular network of the genes altered in U373MG cells
by the anti-cancer chemical compounds
By importing the complete list of Entrez Gene IDs of ei-
ther downregulated or upregulated genes in U373MG
cells after a 24 hour-exposure to the three compounds
into the Functional Annotation tool of DAVID, we iden-
tified the KEGG pathways closely related to the set of
imported genes (Table 2). We found that downregulated
genes in U373MG cells shared among the three com-
pounds showed the significant relevance to the ErbB
(EGFR) signaling pathway (hsa04012), composed of focal
adhesion kinase (FAK), alternatively named protein tyro-
sine kinase 2 (PTK2), v-akt murine thymoma viraloncogene homolog (AKT)/protein kinase B (PKB), and
glycogen synthase kinase 3 (GSK3) acting as central sig-
naling molecules (colored by blue in Figure 6), in
addition to the axon guidance pathway (hsa04360). We
also validated these findings by the Protein Analysis
Through Evolutionary Relationships (PANTHER) classi-
fication system (www.pantherdb.org), operating on the
different computational algorithms from KEGG (Add-
itional file 9 online). The pathways of adherens junction
(hsa04520), focal adhesion (hsa04510), and cell adhesion
molecules (hsa04514) were also enriched in the set of
downregulated genes by these chemical compounds
(Table 2). In contrast, the set of upregulated genes by
both the compounds 1a and 3 showed the most signifi-
cant relationship with the cell cycle pathway (hsa04110)
(colored by orange in Figure 7), where CDC25A serves
as a hub molecule.
The impact factor (IF) analysis by the Pathway-Express
tool indicated that adherence junction (hsa04520) (IF =
29.856) and phosphatidylinositol signaling system
(hsa04070) (IF = 26.696) in the compound 1a, phosphati-
dylinositol signaling system (hsa04070) (IF = 25.067) and
adherence junction (hsa04520) (IF =21.93) in the com-
pound 3, and phosphatidylinositol signaling system
(hsa04070) (IF = 27.965) and adherence junction
(hsa04520) (IF =13.422) in the compound 2a represented
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downregulated genes by these compounds (Additional
file 10).
Next, by importing the complete list of Entrez Gene
IDs of downregulated or upregulated genes in U373MG
cells after a 24 hour-exposure to three compounds into
IPA, we identified the molecular networks most closely
related to the set of imported genes (Table 3). The mo-
lecular networks with functional categories defined by
cellular movement and nervous system development and
function were enriched in the network of the genes down-
regulated by all the three compounds (colored by green in
Figure 8), where GSK3B acts as a hub molecule. In con-
trast, the molecular networks with functional categories
defined by cellular growth and proliferation were overre-
presented in the network of upregulated genes (Table 3).
Finally, the sets of 317 downregulated genes and 30
upregulated genes in U373MG cells shared between the
structurally-related compounds 1a and 3 were combined
together, and then the corresponding Entrez Gene IDs
were imported into KeyMolnet. By using the neighbor-
ing network-search algorithm, we identified the highly
complex network composed of 1588 molecules and 2171
molecular relations, showing the most significant rela-
tionship with the canonical pathway of transcriptional
regulation by retinoblastoma protein (Rb)/E2F transcrip-
tion factors (p = 2.202E-219) (Figure 9).
Because GSK3B acts as a central player in the molecular
network of downregulated genes in U373MG cells by the
three compounds, we determined the direct effect of a
GSK3B inhibitor on the survival of U-373MG cells. Fol-
lowing a 36 hour-exposure to 20 μM GSK3B inhibitor VII,
a cell-permeable and non-ATP competitive inhibitor with
the high specificity for GSK3B, we found induction of
apoptosis of U373MG cells, suggesting an anti-apoptotic
role of GSK3B (Figure 3, panels j, k, lane 16).
Discussion
To identify the molecular pathways responsible for cyto-
toxic effects of novel 1,2,3,4-tetrahydroisoquinoline alka-
loids 1a, 2a, and 3 on U373MG cells, we studied the
genome-wide gene expression profile and molecular net-
works by using pathway analysis tools of bioinformatics.
All of these compounds induced apoptosis of U373MG
cells at physiologically relevant nanomolar concentra-
tions. The compound 3 reduced the expression of 417
genes and elevated the levels of 84 genes, while the com-
pound 1a downregulated 426 genes and upregulated 45
genes. The compound 2a decreased the expression of
274 genes and increased the expression of 9 genes. Im-
portantly, the set of 196 downregulated genes and 6
upregulated genes showed an overlap among all of these
compounds, suggesting an existence of the common
pathways involved in induction of apoptosis. Bymolecular network analysis, we identified the ErbB
(EGFR) signaling pathway, in addition to axonal guid-
ance and cell adhesion pathways, as those of the signifi-
cant pathways in downregulated genes shared among all
the compounds. Importantly, a recent study by combin-
ing genome-wide screening of altered genes and molecu-
lar network analysis identified axonal guidance and cell
adhesion pathways as those enriched in a variety of cel-
lular processes deregulated in human glioblastoma [18].
We found that the ErbB (EGFR) signaling pathway is
composed of FAK/PTK2, AKT3, and GSK3B, serving as
key molecules involved in cell movement and the ner-
vous system development. In contrast, the set of upregu-
lated genes by the compounds 1a and 3 showed the
most significant relationship with the cell cycle pathway,
where CDC25A acts as a hub molecule. Finally, we
found that a GSK3B-specific inhibitor induced apoptosis
of U373MG cells, supporting an anti-apoptotic role of
GSK3B. These observations indicate that molecular
network analysis is a useful approach not only to
characterize the glioma-relevant pathways but also to
identify the network-based effective drug targets.
Being consistent with our observations, downregula-
tion of AKT3 expression by RNA interference reduces
the expression of the phosphorylated form of Bad,
resulting in induction of the caspase-dependent apop-
tosis of glioma cells [19]. AKT3 is required for anchor-
age-independent growth of human glioma cells [20].
GSK3 is a serine/threonine kinase that regulates in an
integrated manner Wnt/β-catenin, Hedgehog, and
receptor tyrosine kinase (RTK) signaling pathways
involved in a wide range of cellular functions, such as
glycogen metabolism, cell differentiation, proliferation,
and apoptosis [21]. Interference with GSK3β activity by
siRNA inhibits cell migration and induces apoptosis of
glioma cells by activating c-Myc and inactivating nuclear
factor-κB (NF-κB) activities [22,23].
The cell cycle progression is positively and negatively
regulated by the complex checkpoint mechanism that
involves cyclins A, B, D, and E, along with cyclin-
dependent kinases (CDKs) and CDK inhibitors (CDKIs)
of both the Cip/Kip and Ink4 families. The hypopho-
sphorylated Rb protein interacts with the E2F family
transcription factors E2F1, E2F2, and E2F3, and activates
the expression of the genes pivotal for cell cycle progres-
sion, whereas the Rb protein, hyperphosphorylated by
cyclin D1-CDK4 and cyclin E1-CDK2 complexes,
releases E2Fs, and represses the expression of cell cycle
genes [24]. Thus, the Rb/E2F pathway constitutes a mo-
lecular switch deciding either progression or arrest of
the cell cycle. By using KeyMolnet, we found that the
molecular network, composed of the combined set of
downregulated and upregulated genes in U373MG cells
shared between the compounds 1a and 3, shows the
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tion by Rb/E2F transcription factors. These observations
suggest that both of the structurally-related tetrahydroi-
soquinoline alkaloids act as a DNA-alkylating agent that
interferes with cell division, leading to apoptosis of tar-
get cells via the mechanisms very similar to those of ET-
743-mediated cytotoxicity [7].
CDC25A encodes a protein phosphatase that activates
cyclin/CDK complexes by removing inhibitory phosphates
from the conserved threonine and tyrosine residues on
CDK proteins. A previous study showed that inhibition of
CDC25A expression induces apoptosis of human glioma
cells [25], seemingly contradictory to upregulation of
CDC25A during induction of apoptosis of U373MG cells
in our study. However, a recent study showed that
CDC25A, by activating cyclin B1 and Cdc2, acts as a proa-
poptotic mediator that enhances staurosporine-induced
apoptosis, supporting our observations [26].
We identified ELMO1 as one of top 10 downregulated
genes and OSR2 as one of top 10 upregulated genes in
U373MG cells exposed to all three compounds. Import-
antly, ELMO1, by forming the complex with dedicator
of cytokinesis 180 (Dock180), serves as a Rac1 guanine
nucleotide exchange factor that stimulates glioma cell
migration and invasion [27]. OSR2 acts as a transcrip-
tion factor for expression of the genes involved in the
epithelial and mesenchymal interaction during craniofa-
cial development and cellular differentiation [28].Conclusion
Molecular network analysis suggested that novel marine-
derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alka-
loids 1a, 2a, and 3 induced apoptosis of glioma cells
through the shared molecular mechanisms involving
multiple pathways and targets that play a pivotal role in
the survival and invasion of glioma cells.Additional files
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